Information  X 
Enter a valid email address

Antisoma plc (SRC)

  Print      Mail a friend       Annual reports

Friday 08 February, 2008

Antisoma plc

Antisoma to present at BIO CEO & Investor C...

8 February 2008, London, UK: Antisoma plc (LSE: ASM; USOTC: ATSMY)
announces that its Chief Executive, Glyn Edwards, will be presenting
at the BIO CEO & Investor Conference in New York.

The presentation is scheduled for 16:15 EST (21:15 GMT) on Tuesday,
February 12th, and a webcast will be available to all on Antisoma's
website at

For live viewing of the webcast, it is recommended that viewers log
on 15 minutes early in order to register and download any necessary

Daniel Elger
Director of Communications
Antisoma plc
+44 7909 915 068

Brian Korb
The Trout Group
+1 212 477 9007

Background on Antisoma
Headquartered in London, UK, Antisoma is a biopharmaceutical company
that develops novel products for the treatment of cancer. Antisoma
fills its development pipeline by acquiring promising new product
candidates from internationally recognised academic or cancer
research institutions. Its core activity is the preclinical and
clinical development of these drug candidates. Please visit for further information.